WHY AMI IS THE ONLY NAME TO TRUST FOR A BETTER SEX LIFE
MI understands effective means to improve sexual health for the past 17 years & 500,000 patients.
iscreet, reliable & effective consultations to put you back in action instantly
alue Added Global presence –to ensure fast relief -for all kinds of Sexual Dyfunctioning
sk us for our Proven Treatments of Erectile Dysfunction & Premature Ejaculation
asal Delivery Technology –to ensure Fast onset of Action
ost Effective Medical Solutions –to Make you Last Longer.
ffective, Verified & Time Tested Medically Backed Results
edication to Quality Assurance for past two decades
edical Practice with experience of Fast Diagnosis of Sexual Health Issues
ffective Treatment Options
irect online Professional, Medical support 24X7
nnovation & constant research in Sexual health to stay at the top
linical Accuracy in Providing Meds –backed up –by a State of Art Pharmacy
uthentic & secure medications & medical practices with Safety net
et us give you the Best times in your Sexual life.
Call the Doctors at AMI Now For a Free Consultation & Enter into a Obligation Free Treatment Program
MORE THAN 500,000 PATIENTS HAVE ALREADY CONSULTED US
AMI operates a major modern centralised call center and 20 specialist medical clinics throughout Australia, New Zealand and China, and has more than 270 staff members, including more than 50 licensed medical personnel.
AMI - Assets
AVMD’s wholly owned subsidiary, AMI operates a centralized call center and twenty medical centers and sales offices throughout Australia, New Zealand and China.
o Patient profiles;
An Australian innovation patent (Australian Innovation Patent No 2005100183, which patent is due to expire on July 9, 2012), an Australian standard patent application (Australian standard patent application No. 2004222783), a worldwide PCT patent application Patent No PCT/AU2004/000931 (WO 2005/004855 A1)) filed with IP Australia and the subsequent individual country applications filed in the United States, Europe, Japan, the People’s Republic of China, India and New Zealand. The patents relate to various methods of treatment delivery via nasal (mucosal) inhalation and topical application of certain formulations used in AVMD’s treatments for premature ejaculation. The patents and associated formulations are integral to those treatments. AVMD’s impotence and erectile dysfunction treatments are not patent protected.